John E Kao $ALHC SEC Form 4 Insider Trading

John E Kao has filed a total of 29 insider trades in $ALHC since 2021. Their most recent trade was a sale of 90,000 shares, made on Dec 11, 2024. Their largest trade was a sale of 500,000 shares, made on Aug 11, 2022. We estimate that they now own 5.1 million shares of $ALHC, worth an estimated $56.1 million.

Insider Trading at $ALHC

There have been a total of 198 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 49.1 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, Dawn Christine Maroney, and John E Kao. The most recent trade was a sale of 30,000 shares reported by Dawn Christine Maroney (President, Markets), made on Dec 16, 2024.

$ALHC Executives and Stock Owners with Insider Trades

• Robert Thomas Freeman, Chief Financial Officer

• Dawn Christine Maroney, President, Markets

• John E Kao, Chief Executive Officer

• Dinesh M. Kumar, Chief Med & Operating Officer

• Christopher J Joyce, Chief Legal and Admin. Officer

• Hakan Kardes, Chief Experience Officer

• Dinesh M. Kumar, Chief Medical Officer

• Joseph S Konowiecki, Chairman of the Board

• Hyong Kim, Chief Medical Officer

• Richard A. Cross, SVP, General Counsel

• Robert L. Scavo, Chief Information Officer

• Donald Steven Furman, Chief Clinical Officer

• Rajesh Shrestha, Pres., New Markets & CBO

• Sebastian Burzacchi, COO - Mgmt Services Org

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.